Eris Lifesciences Limited
MainboardlistedERISINE406M01024- DRHP filed10 Feb 17
- RHP filed12 Jun 17
- Open16 Jun 17
- Close20 Jun 17
- Listed29 Jun 17
Issue
- Price band
- ₹600–603
- Issue price
- ₹603
- Face value
- ₹1
- Lot size
- 24
- Issue size
- ₹1,741.16 Cr
- Fresh / OFS
- not stated yet / ₹1,740.49 Cr
- Issue type
- book built
- Registrar
- Link Intime India Private Limited
- Exchanges
- BSE, NSE
- Sector
- Healthcare
- Industry
- Pharmaceuticals
Returns
- Listing
- -0.3%
- 1 month
- -0.3%
- 3 months
- -4.3%
- 6 months
- +31.7%
- 1 year
- +13.6%
- Current (03 Nov 26)
- +95.3%
Financials · from the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Borrowings | Total assets |
|---|---|---|---|---|---|---|
| FY13 | 417 | 65.8 | ||||
| FY14 | 520.5 | 65.2 | ||||
| FY15 | 548 | 83.3 | ||||
| FY16 | 605.5 | 138 | ||||
| FY17 | 688.4 | 242.6 |
Reservation · share of the net issue the offer document allocates to each category
- qib
- 75%
- nii
- 15%
- retail
- 10%
Subscription
| Category | Exchange | Times subscribed |
|---|---|---|
| employee | NSE | 0.78× |
| nii | NSE | 0.21× |
| qib | NSE | 1.15× |
| retail | NSE | 1.18× |
| total | NSE | 0.89× |
Lead managers
Axis Capital Limited · Citigroup Global Markets India Private Limited · Credit Suisse Securities (India) Private Limited